Resistant and refractory migraine: clinical presentation, pathophysiology, and management
Summary: Migraine is a leading cause of disability worldwide. A minority of individuals with migraine develop resistant or refractory conditions characterised by ≥ 8 monthly days of debilitating headaches and inadequate response, intolerance, or contraindication to ≥3 or all preventive drug classes,...
Main Authors: | Raffaele Ornello, Anna P. Andreou, Eleonora De Matteis, Tim P. Jürgens, Mia T. Minen, Simona Sacco |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-01-01
|
Series: | EBioMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396423005091 |
Similar Items
-
Editorial: Spotlight on resistant and refractory migraine
by: Raffaele Ornello, et al.
Published: (2023-09-01) -
Breaking the cycle: unraveling the diagnostic, pathophysiological and treatment challenges of refractory migraine
by: Jennifer Robblee
Published: (2023-09-01) -
CGRP-targeted medication in chronic migraine - systematic review
by: Renato Oliveira, et al.
Published: (2024-04-01) -
Calcitonin gene relating peptide inhibitors in combination for migraine treatment: A mini-review
by: Tulsi Shah, et al.
Published: (2023-03-01) -
Menstrual Headache in Women with Chronic Migraine Treated with Erenumab: An Observational Case Series
by: Raffaele Ornello, et al.
Published: (2021-03-01)